Life Sciences
SDG’s seminal work in the life sciences industry is widely recognized as having helped create billions of dollars in shareholder value and having transformed the way R&D and portfolio investment decisions are evaluated and implemented. The frameworks developed by SDG for portfolio prioritization are now accepted as best practice in the life sciences industry.
SDG's groundbreaking Life Sciences Practice is now a business unit of IMS Health, a global provider of business intelligence and strategic consulting services for the pharmaceutical and healthcare industries. As part of our ongoing alliance, SDG provides strategy and advisory services to IMS Health's clients in China, India, Korea, Australia, and the ASEAN countries in a range of areas: growth strategy, entry strategy, M&A, and due diligence advisory.
In addition, SDG is IMS Health's preferred education and training partner for our shared clients in life sciences.
